Early research (Phase 1)Ended earlyNCT02369029What this trial is testingBAY1238097, First in ManWho this might be right forNeoplasms Bayer 8
Testing effectiveness (Phase 2)Looking for participantsNCT07050186What this trial is testingCemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT CarcinomaWho this might be right forMetastatic NUT CarcinomaUnresectable NUT Carcinoma Northwestern University 15
Early research (Phase 1)Study completedNCT02516553What this trial is testingBI 894999 First in Human Dose Finding Study in Advanced MalignanciesWho this might be right forNeoplasmsNUT Carcinoma Boehringer Ingelheim 174
Testing effectiveness (Phase 2)Looking for participantsNCT05019716What this trial is testingTesting the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT CarcinomaWho this might be right forAdvanced NUT CarcinomaMetastatic NUT CarcinomaUnresectable NUT Carcinoma National Cancer Institute (NCI) 36
Not applicableLooking for participantsNCT05265429What this trial is testingBiology of Young Lung Cancer Study: The YOUNG LUNG StudyWho this might be right forNon Small Cell Lung CancerSmall Cell Lung CarcinomaNUT Carcinoma Dana-Farber Cancer Institute 500
Not applicableActive Not RecruitingNCT05812027What this trial is testingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid TumorsWho this might be right forHead and Neck CancerCervical CancerNon Small Cell Lung Cancer+4 more TScan Therapeutics, Inc. 1,150
Testing effectiveness (Phase 2)Looking for participantsNCT06943521What this trial is testingMT-4561 in Patients With Various Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more Tanabe Pharma America, Inc. 27
Early research (Phase 1)Looking for participantsNCT05488548What this trial is testingDual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological MalignanciesWho this might be right forCastrate Resistant Prostate CancerNUT CarcinomaChronic Myelomonocytic Leukemia+1 more Epigenetix, Inc. 75
Early research (Phase 1)Study completedNCT01587703What this trial is testingInvestigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other CancersWho this might be right forCarcinoma, Midline GlaxoSmithKline 196
Testing effectiveness (Phase 2)Ended earlyNCT02711137What this trial is testingOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesWho this might be right forSolid Tumors Incyte Corporation 137
Early research (Phase 1)Ended earlyNCT02698176What this trial is testingA Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006)Who this might be right forNUT Midline Carcinoma (NMC)Triple Negative Breast Cancer (TNBC)Non-small Cell Lung Cancer (NSCLC)+1 more Merck Sharp & Dohme LLC 13
Not applicableActive Not RecruitingNCT07459127What this trial is testingMulticenter Retrospective Cohort of Pulmonary NUT CarcinomaWho this might be right forNUT Carcinoma Three Gorges Hospital of Chongqing University 150
Early research (Phase 1)Study completedNCT02259114What this trial is testingA Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)Who this might be right forNUT Midline CarcinomaTriple Negative Breast CancerNon-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation+3 more Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 47
Testing effectiveness (Phase 2)Ended earlyNCT02431260What this trial is testingAn Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced MalignanciesWho this might be right forSolid Tumors and Hematologic Malignancy Incyte Corporation 69
Early research (Phase 1)Looking for participantsNCT05372640What this trial is testingTesting the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+5 more National Cancer Institute (NCI) 45
Early research (Phase 1)Study completedNCT02307240What this trial is testingOpen Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid TumorsWho this might be right forTriple-Negative Breast CancerHigh-grade Serous Ovarian CancerSolid Tumors+1 more Curis, Inc. 43
Not applicableLooking for participantsNCT07072143What this trial is testingAn International Study on Pediatric Patients With Rare Tumors.Who this might be right forParaganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)+11 more Azienda Ospedaliera di Padova 6,250
Not applicableNo Longer AvailableNCT03702036What this trial is testingCompassionate Use Individual Request Program for GSK525762 in NUT Midline CarcinomaWho this might be right forSolid Tumours GlaxoSmithKline
Testing effectiveness (Phase 2)WithdrawnNCT04116359What this trial is testingTesting of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT CarcinomaWho this might be right forMetastatic NUT CarcinomaUnresectable NUT Carcinoma National Cancer Institute (NCI)